3d systems expands orthopedic surgical planning portfolio receiving fda clearance for key ankle indications

Rock hill, s.c., sept. 11, 2024 (globe newswire) -- today, 3d systems (nyse:ddd) announced the food and drug administration (fda) has provided 510(k) clearance for total ankle patient-matched guides to be used with smith+nephew's salto talaris◊ total ankle prosthesis and cadence◊ total ankle system. the products feature individualized pre-surgical planning and a patient-specific 3d-printed instrument set that ensures accurate implant alignment and sizing for tailored total ankle replacement surgery. the collaboration between 3d systems and smith+nephew, the global medical technology company, achieved these patient-matched solutions that enable surgeons to prepare the bony anatomy of the tibia and talus for placement of implants intended to restore proper function of the ankle joint. these patient-matched guides are engineered and manufactured using 3d systems'  vsp ® surgical planning solutions  that combine best-in-class digital workflows with the industry's broadest additive manufacturing portfolio of printers and materials.
DDD Ratings Summary
DDD Quant Ranking